Association Between Pilatis Exercise, Balance and Stability Measurements, and Quality of Life Among Elderly Population
NCT ID: NCT01379235
Last Updated: 2014-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
88 participants
INTERVENTIONAL
2012-01-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Working hypothesis and aims: Pilatis exercise will improve balance and stability measurements, and quality of life among elderly population.
Methods: Randomized, prospective study among elderly patients aged 65 and above belonging to Clalit Health Services primary care clinic . Participants of the intervention and control group will receive a brochure that will include nutrition and healthy life style recommendations. Intervention group: will receive 12 weeks of pilatis exercise 3 times a week. The control group will be offered the same intervention at the end of the study period. Balance evaluation will be performed using the: Tinetti Balance Gait Scale, Berg Balance Scale, Multidirectional Reach Test, Timed Up and Go, Step execution test. The SF-36 questionnaire will be use to evaluate quality of life.
Importance: This study will examine the influence of pilatis exercise on balance among the elderly. If findings will determine that pilatis does improve balance in the elderly, the investigators can further examine pilatis's influence on falls prevention, and minimizing falls damages.
Probable implications to the welfare and health of the aged population:
Improving balance, falls preventing and minimizing falls damages among elderly; improvement in elderly quality of life.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Intervention group: will receive 12 weeks of pilatis exercise 3 times a week.
Pilatis exercise
12 weeks of pilatis exercise 3 times a week.
control group
The control group will be offered the same intervention (pilatis exercise) at the end of the study period.
Pilatis exercise
12 weeks of pilatis exercise 3 times a week.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pilatis exercise
12 weeks of pilatis exercise 3 times a week.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to walk independently without devices (cane is exceptable)
Exclusion Criteria
2. MMSE less then 24
3. After hip or knee surgery
4. After lower limb amputation
5. Neurological diseases with significant gait and balance instability.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Meir Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yan Press, MD
Role: PRINCIPAL_INVESTIGATOR
Ben-Gurion University of the Negev
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clalit Health Services (HMO)
Beersheba, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MMC105809KCTIL
Identifier Type: -
Identifier Source: org_study_id